Evaluation of p21(WAF1/CIP1) and cyclin D1 expression in the progression of superficial bladder cancer

Urological Research

Volumn 28, Issue 5, 2000, Pages 285-292

  Liukkonen, T ^a   Lipponen, P ^b   Raitanen, M ^c   Kaasinen, E ^d   Ala Opas, M ^e   Rajala, P ^f   Kosma, V M ^e  

^a MIKKELI CENTRAL HOSPITAL   (Finland)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d HYVINKÄÄ HOSPITAL   (Finland)

^e KUOPIO UNIVERSITY HOSPITAL   (Finland)

^f TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Cyclin D1; p21(WAF1 CIP1); Prognosis; Superficial bladder cancer

Indexed keywords

CYCLIN D1; PROTEIN P21; CDKN1A PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE INHIBITOR 1A; CYCLINE;

ADULT; AGED; ARTICLE; BLADDER CARCINOMA; CANCER GRADING; CANCER SURVIVAL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; WORLD HEALTH ORGANIZATION; BLADDER TUMOR; CANCER STAGING; CELL DIVISION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DISEASE COURSE; METABOLISM; MIDDLE AGED; PATHOLOGY; RANDOMIZED CONTROLLED TRIAL; TRANSITIONAL CELL CARCINOMA; TUMOR RECURRENCE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, TRANSITIONAL CELL; CELL DIVISION; CYCLIN D1; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS; RANDOMIZED CONTROLLED TRIALS; URINARY BLADDER NEOPLASMS;

EID: 0033752803     PISSN: 03005623     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002400000116     Document Type: Article

References (53)

1. Prognostic value and expression of p21(waf1/cip1) protein in prostate cancer
2. Should pT1 transitional cell cancers of the bladder still be classified as superficial
3. p21(WAF1/CIP1) and transforming growth factor B1 protein expression correlate with survival in non-small cell lung cancer
4. Expression of cyclin D1 and EMS1 in bladder tumours; relationship with chromosome 11q13 amplification
5. Interaction between bcl-2 and p21(WAF1/CIP1) in breast carcinomas with wild-type p53
6. p53, Through p21(WAF1/CIP1), induces cyclin D1 synthesis
7. Frequent and heterogenous expression of cyclin-dependent kinase inhibitor WAF1/p21 protein and mRNA in urothelial carcinoma
8. Mutation of cell cycle regulators. Biological and clinical implications of human neoplasia
9. Transforming growth factor b induces the cyclin-dependent kinase inhibitor p21 through a p53-independent mechanism
10. Cyclin D1 and human neoplasia
11. Physical interaction of the retinoplastoma protein with human D cyclins
12. WAF1, a potential mediator of p53 tumor suppression
13. Topological control of p21(WAF1/CIP1) expression in normal and neoplastic tissues
14. Aberrant p21(CIP1/WAF1) protein accumulation in head- and neck cancer
15. Cyclin D1 and prognosis in breast cancer
16. Cell cycle control in mammalian cells: Role of cyclins, cyclin-dependent kinases (CDKs), growth suppressor genes and cyclin-dependent kinase inhibitors (CKIs)
17. Genetic alterations of cyclins, cyclin-dependent kinases, and cdk inhibitors in human cancer
18. Cell cycle control and cancer
19. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins
20. bcl-2 Is an inner mitochondrial membrane protein that blocks programmed cell death
21. bcl-2 protein expression and long-term survival in breast cancer
22. Abrogation of apoptosis induced by DNA-damaging agents in human bladder-cancer cell lines with p21(waf1/cip1) and/or p53 gene alterations
23. p21 Expression as a predictor for favorable prognosis in squamous cell carcinoma of the lung
24. Expression of retinoblastoma gene product and p21(WAF1/Cip1) protein in gliomas: Correlations with proliferation markers, p53 expression and survival
25. Analysis of p21(WAF1/CIP1) in primary bladder tumors
26. Significance of cyclin D1 overexpression in transitional cell carcinomas of the urinary bladder and its correlation with histopathologic features
27. Over-expression of p53 nuclear oncoprotein in transitional-cell bladder cancer and its prognostic value
28. Expression of the apoptosis suppressing bcl-2 protein in transitional cell bladder tumours
29. Expression of p21(waf1/cip1) protein in transitional cell bladder tumours and its prognostic value
30. Expression of MIB-1, mitotic index and S-phase fraction as indicators of cell proliferation in superficial bladder cancer
31. Immunoreactivity of bcl-2, p53 and EGFr is associated with tumor stage, grade and cell proliferation in superficial bladder cancer
32. The prognostic value of MIB-1 score, p53, EGFr, mitotic index and papillary status in primary superficial (stage pTa/T1) bladder cancer: A prospective comparative study
33. WAF1/p21 regulates proliferation, but does not mediate p53-dependent apoptosis in urothelial carcinoma cell lines
34. A clinico-pathological study on overexpression of cyclin D1 and of p53 in a series of 248 patients with operable breast cancer
35. Induction of waf1/CIP1 by a p53-independent pathway
36. A novel cyclin encoded by a bcl-1 linked candidate oncogene
37. International histological classification of tumours
38. An analysis of the performance of pathologists in grading bladder tumors
39. Expression of cyclin D1, but not cyclins E and A, is related to progression in bilharzial bladder cancer
40. Transurethral resection with perioperative instillation of interferon-a or epirubicin for the prophylaxis of recurrent primary superficial bladder cancer: A prospective randomized multicenter study - Finnbladder III
41. Sources of variation in the assessment of cell proliferation using proliferating cell nuclear antigen immunohistochemistry
42. Prognostication of astrocytoma patient survival byKi-67 (MIB-1), PCNA and S-phase fraction using archival paraffin-embedded samples
43. Nuclear overexpression of p53 protein in transitional cell bladder carcinoma: A marker for disease progression
44. Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers
45. Loss of p21(WAF/CIP1) protein expression accmpanies progression of sporadic colorectal neoplasms but not hereditary nonpolyposis colorectal cancers
46. Two molecular pathways to transitional cell carcinoma of the bladder
47. Effect of p21(WAF1/CIP1) expression on tumor progression in bladder cancer
48. Prognostic markers in bladder cancer: A contemporary review of the literature
49. Cyclin D1 protein overexpression is related to tumor differentiation, but not to tumor progression or proliferative activity, in transitional cell carcinoma of the bladder
50. p21(Waf1/Cip1) and p53 protein expression in breast cancer
51. D type cyclins associate with multiple protein kinases and the DNA replication and repair factor PCNA